P3 Health Partners Stock Current Valuation
| PIIIW Stock | USD 0.01 0 7.14% |
Valuation analysis of P3 Health Partners helps investors to measure P3 Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to climb to about 398.5 M in 2025, whereas Enterprise Value Over EBITDA is likely to drop (2.45) in 2025.
Overvalued
Today
Please note that P3 Health's price fluctuation is out of control at this time. Calculation of the real value of P3 Health Partners is based on 3 months time horizon. Increasing P3 Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PIIIW stock is determined by what a typical buyer is willing to pay for full or partial control of P3 Health Partners. Since P3 Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PIIIW Stock. However, P3 Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.013 | Real 0.0115 | Hype 0.01 | Naive 0.0176 |
The intrinsic value of P3 Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence P3 Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of P3 Health Partners helps investors to forecast how PIIIW stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of P3 Health more accurately as focusing exclusively on P3 Health's fundamentals will not take into account other important factors: P3 Health Partners Company Current Valuation Analysis
P3 Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
PIIIW Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for P3 Health is extremely important. It helps to project a fair market value of PIIIW Stock properly, considering its historical fundamentals such as Current Valuation. Since P3 Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of P3 Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of P3 Health's interrelated accounts and indicators.
Click cells to compare fundamentals
PIIIW Current Valuation Historical Pattern
Today, most investors in P3 Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various P3 Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of P3 Health current valuation as a starting point in their analysis.
P3 Health Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, P3 Health Partners has a Current Valuation of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
P3 Health Partners is currently under evaluation in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 219.38 Million. P3 Health adds roughly 0.0 in current valuation claiming only tiny portion of equities under Health Care industry.PIIIW Fundamentals
| Return On Equity | -0.65 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.31) % | ||||
| Number Of Shares Shorted | 11.72 K | ||||
| Revenue | 1.27 B | ||||
| Gross Profit | (40.2 M) | ||||
| EBITDA | (81.07 M) | ||||
| Net Income | (57.77 M) | ||||
| Cash And Equivalents | 4.34 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 121.94 M | ||||
| Current Ratio | 0.45 X | ||||
| Book Value Per Share | 0.74 X | ||||
| Cash Flow From Operations | (76.03 M) | ||||
| Earnings Per Share | (1.34) X | ||||
| Number Of Employees | 400 | ||||
| Beta | 0.93 | ||||
| Total Asset | 860.97 M | ||||
| Retained Earnings | (367.34 M) | ||||
| Working Capital | (133.35 M) | ||||
| Net Asset | 860.97 M |
About P3 Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze P3 Health Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of P3 Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of P3 Health Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for PIIIW Stock Analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.